Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.
Press releases published on April 15, 2025
Kraig Biocraft Laboratories Announces the Launch of Advanced Gene-Splicing Program and New Transgenics
GlobeNewswire
·
April 15, 2025
ANN ARBOR, Mich., April 15, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology1, today announced the successful rollout of a next-generation molecular biology and …
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2025 financial results before the market opens on Monday, …
Axonius Appoints Former Disney CISO Ryan Knisley as Chief Product Strategist
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of Ryan Knisley as Chief Product Strategist. Knisley brings …
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting
GlobeNewswire
·
April 15, 2025
ACTON, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), today announced acceptance of an abstract related to the Symphony IL-6 Test, the company’s lead product candidate, for presentation at the Society of Academic …
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
GlobeNewswire
·
April 15, 2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the …
Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
GlobeNewswire
·
April 15, 2025
Company to share new preclinical combination data for FHD-909 (LY4050784), a potential first-in-class selective SMARCA2 inhibitor, with non-small cell lung cancer (NSCLC) as the primary target population Additional updates include new preclinical data for …
Accelerating the Adoption of AI Solutions for the Enterprise - Climb Channel Solutions and Unframe Sign Global Distribution Partnership
GlobeNewswire
·
April 15, 2025
-Fresh from a $50M round of investment, Unframe is now eyeing North America and EMEA growth- -Partnership with Climb will enable resellers and enterprises to access Unframe’s platform and deliver cutting-edge AI solutions at scale- EATONTOWN, N.J., April …
Mercury and Cicor Group Create Long-Term Strategic Business Relationship In Support of European Defense
GlobeNewswire
·
April 15, 2025
ANDOVER, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, today announced it has entered into a strategic supply agreement under …
Aduro Clean Technologies Reports Third Quarter Fiscal 2025 Results
GlobeNewswire
·
April 15, 2025
LONDON, Ontario, April 15, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste …
Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model
GlobeNewswire
·
April 15, 2025
Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates superior potency of nimacimab’s differentiated and favorable …
Kaspi.kz to Announce 1st Quarter 2025 Financial Results on 12th May
GlobeNewswire
·
April 15, 2025
ALMATY, Kazakhstan, April 15, 2025 (GLOBE NEWSWIRE) -- Kaspi.kz (KSPI US) will report its financial results for the quarter March 31, 2025, on Monday, 12th May, 2025. On that day, management will hold a conference call and webcast at 8.00am EST (1pm GMT, 5 …
Castellum, Inc.’s Subsidiary GTMR Adds Professional Services to its Current GSA MAS Contract
GlobeNewswire
·
April 15, 2025
VIENNA, Va., April 15, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) (“Castellum” or “CTM”), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that its subsidiary …
Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit
GlobeNewswire
·
April 15, 2025
HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Randall Moreadith, M. …
Native Path Native Hydrate Reviews [Urgent Update]: Don’t Buy Until You Read This
GlobeNewswire
·
April 15, 2025
Native Hydrate by Native Path Reviews Woodhaven, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- What if the key to better hydration and muscle recovery wasn’t in sugary sports drinks but in a clean, science-backed formula? Native Hydrate by Native Path is …
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2025
GlobeNewswire
·
April 15, 2025
Company Announcement Net sales of DARZALEX® in the first quarter of 2025 totaled USD 3,237 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; April 15, 2025 – …
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
GlobeNewswire
·
April 15, 2025
LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the first quarter ended March 31, 2025 on Tuesday, April 29, 2025 and …
Medāna Enters the Spanish Market with an AI Platform to Transform Healthcare Across Europe
GlobeNewswire
·
April 15, 2025
LISBON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Spain is about to welcome one of the most disruptive technologies in digital health. Medāna (www.medana.ai), the global startup founded by Dr. Tal Patalon , has announced its strategic entry into the …
MEDĀNA ENTRA EN EL MERCADO ESPAÑOL CON UNA PLATAFORMA DE IA PARA TRANSFORMAR LA SANIDAD EN TODA EUROPA
GlobeNewswire
·
April 15, 2025
LISBOA, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- España está a punto de recibir una de las tecnologías más disruptivas en salud digital. Medāna (www.medana.ai), startup internacional fundada por la Dra. Tal Patalon, ha anunciado su entrada estratégica …
Medāna Enters the Netherlands Market with an AI Platform to Transform Healthcare Across Europe
GlobeNewswire
·
April 15, 2025
LISBON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Netherlands is about to welcome one of the most disruptive technologies in digital health. Medāna (www.medana.ai), the global startup founded by Dr. Tal Patalon, has announced its strategic entry into …
MEDĀNA BETREEDT DE NEDERLANDSE MARKT MET EEN AI-PLATFORM OM DE GEZONDHEIDSZORG TE TRANSFORMEREN IN EUROPA
GlobeNewswire
·
April 15, 2025
LISSABON, Portugal, April 15, 2025 (GLOBE NEWSWIRE) -- Nederland staat op het punt een van de meest baanbrekende technologieën in de digitale gezondheidszorg te verwelkomen. Medāna (www.medana.ai), de startup opgericht door Dr. Tal Patalon, heeft zijn …